Akari Therapeutics (AKTX) Receivables - Net (2011 - 2013)

Akari Therapeutics (AKTX) reported Receivables - Net of $6000.0 for Q4 2013, down 50.0% on a YoY basis from $12000.0 in Q4 2012, and down 50.0% sequentially from $12000.0 in Q4 2012.

Akari Therapeutics (AKTX) Receivables - Net (2011 - 2013) Analysis & Trends

Akari Therapeutics (AKTX) has 3 years of Receivables - Net data on file, last reported at $6000.0 in Q4 2013.

  • For the quarter ending Q4 2013, Receivables - Net fell 50.0% year-over-year to $6000.0; the trailing twelve-month figure through Dec 2013 stood at $6000.0 (down 50.0% YoY), and the FY2013 full-year result was $6000.0, down 50.0% from the prior year.
  • Receivables - Net eased to $6000.0 in Q4 2013, from $12000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $19000.0 in Q4 2011 to a low of $6000.0 in Q4 2013.
  • A 3-year average of $12333.3 and a median of $12000.0 in 2012 frame the typical range for Receivables - Net.
  • Across the five-year window, Receivables - Net tumbled 36.84% in 2012 and slumped 50.0% in 2013, its largest moves.
  • Tracing AKTX's Receivables - Net over 3 years: stood at $19000.0 in 2011, then slumped by 36.84% to $12000.0 in 2012, then tumbled by 50.0% to $6000.0 in 2013.
  • Business Quant data shows AKTX's Receivables - Net at $6000.0 in Q4 2013, $12000.0 in Q4 2012, and $19000.0 in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2013 6,000.00
Dec 31, 2013 6,000.00
Dec 31, 2012 12,000.00
Dec 31, 2012 12,000.00
Dec 31, 2011 19,000.00
Dec 31, 2011 19,000.00